PIH59 Where is Your Abdomen? Patient-Reported Abdomen Locations and Implications for Patient-Reported Outcome Assessments  by Cala, ML et al.
A742  VA L U E  I N  H E A LT H  1 8  ( 2 0 1 5 )  A 3 3 5 – A 7 6 6  
23 items, accounting for 72.8% of variance. Internal reliability for the 3 domains was 
high (Cronbach’s α .84-.96), as was test-retest reliability (intra-class correlation .81-
.96). Concurrent validity was demonstrated through highly significant relationships 
with relevant domains of the SF-36 and the EQ-5D-5L. ConClusions: Preliminary 
results suggest that the Ox-PAQ is a short, valid and reliable measure of participation 
and activity. The measure will now be validated in a range of further conditions and 
additional properties, such as sensitivity to change and predictive validity, will also 
be assessed in the next phase of the instrument’s development.
PIH57
PatIent-RePoRted outcomes In studIes PublIsHed In 2014: WHIcH 
dIsease aReas Have been tHe maIn Focus oF clInIcal ReseaRcH?
Martin A
Crystallise Ltd., London, UK
objeCtives: To determine the disease focus of all papers indexed in the 
PubMed database that included patient-reported outcomes and were published 
in 2014. Methods: An evidence surveillance process was established based on 
a systematic search of PubMed, using key words relevant to the assessment of 
quality of life and patient-reported outcomes and limited to studies published 
in English, in humans, with abstracts, and either clinical trials, observational or 
validation studies or systematic reviews. The surveillance incorporated all studies 
published from 2010 and was updated weekly. Abstracts identified by the search 
that included patient-reported outcomes were indexed according to disease area, 
using the chapter categorisation from ICD-10 as a framework. Articles were included 
if they reported results or a study protocol from a primary research study or were a 
systematic review. To account for the delay in indexing of publications, we included 
all studies with a publication date of 2014 that were indexed in PubMed up to 18 
May 2015. Results: The search identified 1,980 articles published in 2014, 1713 of 
which met the inclusion criteria. Of these, 19% were conducted in patients with 
cancer, 12% in musculoskeletal disorders, 10% in respiratory disorders, 9% in uro-
genital disorders, 9% in mental health disorders, 8% in cardiovascular diseases, 7% 
in gastrointestinal disorders and 5% in neurological disorders. All other disease 
areas were relatively underrepresented, accounting for 4% or fewer of the relevant 
publications. ConClusions: The preponderance of patient-reported outcome 
studies in patients with cancer reflects the focus of pharmacological research on 
this topic. Disease areas such as endocrinology and diabetes (4% of abstracts), infec-
tious diseases (2%), acute trauma (1%) and pregnancy (< 1%) have been relatively 
under-researched for their impact on quality of life, despite their substantial impact 
on morbidity and mortality internationally.
PIH58
tHe concePtual FRameWoRk and content valIdIty oF tHe PolycystIc 
ovaRy syndRome PatIent RePoRted outcome (Pcos-PRo) scale
Reaney M1, Paty J2, Black P3, Celeste Elash CA3, Martin ML4, Eek D5
1ERT, Peterborough, UK, 2Quintiles, Hawthorne, NY, USA, 3ERT, Pittsburgh, PA, USA, 4Health 
Research Associates, Inc., Seattle, WA, USA, 5Astra Zeneca, Molndal, Sweden
objeCtives: A comprehensive disease model of PCOS demonstrated that polycystic 
ovary syndrome (PCOS) presents with a broad range of symptoms and has significant 
impacts on patients’ lives. There are no patient-reported outcome (PRO) instruments 
that are well-defined, comprehensive in coverage and reliable for capturing symptoms 
and impacts in women who experience PCOS. The PCOS-PRO was therefore developed 
following the principles outlined in the 2009 FDA PRO Guidance. Methods: The 
following steps were undertaken: (1) a targeted review of the literature, interviews 
with clinical experts, and concept elicitation interviews with PCOS patients were 
conducted to inform a comprehensive disease model of the signs/symptoms and 
impacts most important to women with PCOS; (2) a conceptual framework for the 
PCOS-PRO was designed to reflect the concepts to be measured and their antici-
pated relationships; (3) items were drafted, using patient language derived from 
the interviews; (4) cognitive interviews were conducted with patients to evaluate 
patient comprehension; (5) the conceptual framework was revised and the PCOS-
PRO finalized. Results: The final PCOS-PRO has 39 items measuring menstruation 
symptoms, the daily symptoms of PCOS (pain, cramping, bloating, hirsutism, acne, 
darkened skin, alopecia), and the daily impacts of PCOS (activities of daily living, rest, 
physical limitations, exercise, emotional health, engagement in coping behaviours). 
Most items are evaluated on 11-point numeric rating scales (NRS) anchored with “no 
[symptom/impact]” and “[symptom/impact] as bad as I can imagine”, or “not difficult” 
and “extremely difficult”. The PCOS-PRO has been developed on an e-diary with a 24 
hour recall period for daily use. ConClusions: Establishing content validity involves 
ensuring that instrument items assess concepts that are relevant for the patient 
population, cover all important aspects of the targeted concepts, and are understood 
by patients. The results of this research support the content validity of the PCOS-PRO. 
Other measurement properties are pending evaluation.
PIH59
WHeRe Is youR abdomen? PatIent-RePoRted abdomen locatIons and 
ImPlIcatIons FoR PatIent-RePoRted outcome assessments
Cala ML1, Witherspoon B1, Evans C1, Dallabrida S2
1Endpoint Outcomes, Boston, MA, USA, 2ERT, Boston, MA, USA
objeCtives: This research aims to provide clarity regarding the location of the 
abdomen from the patient perspective, and the implications that this has for estab-
lishing content valid PRO measures of symptoms experienced in the anatomical 
region. Methods: The dataset included 419 adult participants with either chronic 
obstructive pulmonary disease, depression, osteoarthritis, or type II diabetes. 
Participants were asked to circle the abdomen on a diagram of a body. A grid of 13 
regions, nine of which were used to define the abdomen, was used to analyze which 
region(s) was identified as the abdomen. Results: The average age of the partici-
pants was 55.3 years and they were predominantly female (52.0%) and black (48.0%). 
Only 20.0% achieved a college or advanced degree. 411 participants (98.1%) circled at 
least one part of the abdomen; only 8 participants (1.9%) circled something exclusively 
was more common for premature delivery (p < 0.001). ConClusions: Based on the 
results it can be said that in the study population the education of pregnant women 
was influence to their health-conscious. Among pregnant women who smoked 
less hemoglobin and red blood cell values were experienced which have indirect 
harmful effects to fetus. Anxiety was observed at primiparae, and they were more 
common in premature birth.
PIH54
PatIents’ and HealtH PRoFessIonals’ PReFeRences RegaRdIng 
IntRavenous vs subcutaneous dRug admInIstRatIon: a lIteRatuRe 
RevIeW
Tsiantou V1, Athanasakis K1, Theodoropoulou F2, Kyriopoulos J1
1National School of Public Health, Athens, Greece, 2Roche Hellas, Athens, Greece
objeCtives: Measurement of preferences gives a quantitative understanding of 
the value that a person places on a medication or a health intervention. The aim 
was to review the evidence regarding patients’ and health professionals’ prefer-
ences towards IV and SC drug administration Methods: A literature review was 
conducted through PUBMED, Google Scholar and ISPOR DATABASE. A hand search 
was also performed in retrieved papers that were included in the final analysis 
to identify additional relevant papers. Search terms used were ‘preference’ AND 
‘IV vs. SC’ OR ‘IV versus SC’ OR ‘intravenous vs. subcutaneous’ OR ‘intravenous 
versus subcutaneous’. Studies should be written in English, published after 2000 
and participants should be adults. Reviews, studies comparing IV and/or SC over 
other routes of drug administration and not evaluating preferences, were excluded 
from the study. Results: 424 papers were retrieved and 8 were identified through 
hand search. Finally, 20 studies met the inclusion criteria. The majority focused on 
patients’ preferences and only 5 studies measured health professionals’ preferences. 
Very few studies used stated-preferences techniques. In 4/5 studies health profes-
sionals stated that they prefer SC administration. No study gave the reasons for 
this preference. In general, patients preferred SC over IV administration. The main 
reasons for that were time, convenience and location. Patients’ age seemed to be 
also important in shaping preferences. ConClusions: In the majority of studies 
patients and physicians prefer SC vs. IV as the route of administration. Patients’ 
education in SC drug administration will increase their confidence regarding self-
injections and the use of SC drug administration. The role of physicians and nurses 
is crucial towards this target. There is a need to identify the specific attributes that 
define health professionals’ preferences regarding the route of administration and 
to develop validated tools to elicit preferences that do not require high degree of 
expertise.
PIH55
tHeRaPeutIc ReFeRence PRIcIng system In slovenIa FRom tHe PatIents’ 
PeRsPectIve
Mardetko N, Kos M
University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia
objeCtives: The therapeutic reference pricing system in Slovenia was imple-
mented for proton pump inhibitors in 2013 and for angiotensin-converting 
enzyme inhibitors and lipid-lowering medicines in 2014. The study aimed to assess 
patients’ knowledge and attitude towards the therapeutic reference pricing sys-
tem. Methods: A representative sample of 676 patients that had been prescribed 
at least one medicine from the three therapeutic classes was surveyed. The survey 
was carried out from 15th May to 15thJune 2014 in 40 community pharmacies with 
the help of the pharmacists, who filled in the first part of the questionnaire in the 
presence of the patients. The second part of the questionnaire was filled in by 475 
patients at home and returned by prepaid mail. Results: Statements describing 
the patient’ rights and duties within the therapeutic reference pricing (TRP) sys-
tem were only known by approx. 50% of the patients or fewer in most of the cases 
presented to them. Of particular concern are elderly, patients with worse health 
condition, and low-income patients that expressed poorer knowledge about the TRP 
system. The patients had an inhomogeneous view of the necessity and benefits of 
the TRP system, including its potential for cost containment. Most of them regarded 
the TRP system as an unnecessary burden, which could even reduce confidence in 
the Slovenian health care system. Among the 50.4 % that were required to co-pay 
due to the TRP system, 46.7% actually co-paid for their medicine, while 3.7% of 
the patients rejected co-payment. On average, the co-payment was 6.92 EUR per 3 
months of therapy, while the average willingness to pay expressed in the study was 
10.4 EUR for three months of treatment. ConClusions: The results of the present 
study indicate that the implementation of the TRP system and potential upgrades 
in the future represent a significant challenge for patients.
PIH56
tHe oxFoRd PaRtIcIPatIon & actIvItIes QuestIonnaIRe (ox-PaQ): 
PsycHometRIc analysIs
Morley D1, Dummett S1, Dawson J1, Fitzpatrick R1, Churchman DR2, Kelly L1, Jenkinson C1
1University of Oxford, Oxford, UK, 2Isis Innovation Ltd, Oxford, UK
objeCtives: There is growing interest in the management of long term condi-
tions and keeping people active and participating in the community. Testing the 
effectiveness of interventions which aim to impact upon activities and participa-
tion, however, can be challenging without the availability of a well-developed, valid 
and reliable instrument. The objective of this study was to develop and validate a 
fully FDA compliant patient reported outcome measure, the Oxford Participation 
and Activities Questionnaire (Ox-PAQ), theoretically grounded in the World Health 
Organisation International Classification of Functioning, Disability and Health 
(ICF). Methods: Questionnaire items generated from patient interviews and based 
on the nine chapters of the ICF were administered by postal survey to 386 people 
with three neurological conditions; Parkinson’s disease, amyotrophic lateral sclero-
sis, and multiple sclerosis. Participants also completed the MOS 36-Item Short Form 
Survey (SF-36) and EQ-5D 5L. Results: 334 participants completed the survey, a 
response rate of 86.5%. Factor analytic techniques identified 3 domains, consisting of 
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reviewing how the use of a structured model for emotions can improve PRO instru-
ment development by strengthening the role of emotions during CE. Methods: 
A literature review of CE with emotional motivations was undertaken to iden-
tify the most salient aspects for PRO instrument development. Results: The 
method for eliciting emotional motivations is based on motivation research and 
extraction techniques (see Forbes, 2010) containing, nine distinct categories of 
emotional motivation. The CE protocol relies upon neuroscience research (see 
Damasio 2010) which points to the power of a sub-800 millisecond response frame 
for eliciting purely emotional reactions to stimuli. Images validated in large sam-
ple research as uniquely evoking one of the nine motivational emotions are the 
stimuli for this emotional evocation procedure. This augmentation to typical CE 
has been used repeatedly to identify needs for emotional health among suffer-
ers of diabetes, arthritis, and heart disease – in each case linking evocations to 
absence of needed emotional energies that could promote self-care and disease 
recovery. ConClusions: CE techniques for most PRO development do not allow 
investigators to sufficiently understand the patient experiences of physical symp-
toms, effect of ADLs, and the emotional consequences of a disease or condition of 
interest. Adding emotional motivation techniques to CEs will broaden our ability 
to capture the emotional experiences of patients so that related PRO instrument 
items may better represent the experiences of patients’ suffering from various 
medical conditions.
PIH63
InadeQuate tReatment oF Post-suRgIcal PaIn may Result In extended 
HosPItalIzatIon PeRIod
Ferreira CN1, Santana CF1, Rufino CS1, PaloniEd 2, Paiva EC2, Fahham L3, Ribeiro AP1, 
Mazza DD4
1Pfizer, São Paulo, Brazil, 2Orizon, Barueri, Brazil, 3Sense Company, São Paulo, Brazil, 
4Universidade Federal de São Paulo, São Paulo, Brazil
objeCtives: Demonstrate through a retrospective analysis of secondary data, 
that patients with inadequate treatment of post-surgical appendectomy and colic 
renal pain may end up having a longer period of hospitalization. Methods: A 
retrospective administrative claims database containing over 18 millions lives from 
Brazilian private hospitals (ORIZON database), was assessed (from January through 
June 2014), of patients who underwent a surgical intervention by appendectomy 
(n= 1,618) or who had an episode of renal colic and nefretic syndrome (n= 6,555) 
identified by International Codes Disease (N20, N21, N22, N23) and who received 
one of the nonsteroidal anti-inflammatory drugs (NSAIDs) available in the market 
(parecoxib, tenoxicam, and ketoprofen, ketorolac) for pain treatment. After patient 
identification, the average period of hospital permanence was assessed by drug 
group. . Median time differences between groups were assessed thru Kruskal-Wallis 
method. A significance level of 5% was adopted. All statistical analysis were per-
forme in R, version 3.1.1. Results: The average period of hospital permanence 
for the appendectomy procedure was 2.20 days (medical calculations from private 
hospitals round it to 3 days) group of (tenoxicam, ketoprofen, ketorolac) versus 1.95 
(p= 0.006) in the parecoxib, respectively. In the episodes of renal colic, we had 33 
hours versus 25 hours (p < 0.001) in the group of (tenoxicam, ketoprofen, ketorolac) 
versus (parecoxib), respectively. ConClusions: Pain is the one of the critical signs 
in clinical evolution, quality care and outcome disease. The period of hospital per-
manence after surgery or during renal colic or nefretic syndrome treatment is the 
utmost importance and implies in hospital costs. The longer patients stay in hospi-
tal higher is the probability of clinical complication, delaying treatment and some 
cases to increase mortality. The adequate treatment may reduce hospital stay and 
improve assistance as well as financial results
PIH64
satIsFactIon WItH lIFe oF geneRal PoPulatIon oF PakIstan. a natIon 
WIde suRvey
Akram A1, ul Haq N1, Riaz S1, Ahmed N1, Hamid R2
1University of Balochistan, Quetta, Pakistan, 2University of Milan, Milan, Italy
objeCtives: To evaluate the Satisfaction with life among general population 
of Pakistan. Methods: A cross sectional, descriptive study was undertaken 
with study population responding to internet survey, living all over Pakistan. 
Satisfaction with life was assessed using Ed diener SWLS scale. Descriptive analy-
sis was used to elaborate people’s demographic characteristics while inferential 
statistics were applied to report the association among study variables. Results: 
Out of 2203 questionnaires filled 1507 were from Pakistan. Gender distribution was 
761 (50.5%) males. Most popular age group of study participants was 20-25 years 
(46.6%) with 340 (22.6%) married and 669 (44.4%) having graduate level education. 
Overall 460 (30.5%) participants were satisfied with their lives and 190 (12.6%) were 
extremely satisfied from their lives. One hundred and sixty seven (11.1%) and 38 
(2.5%) participants were dissatisfied and extremely dissatisfied from their lives 
respectively. Age and marital status had no association with satisfaction of life. 
Profession is one factor in dissatisfaction towards life. People in urban locality have 
positive trend of satisfaction when compared with the rural ones. ConClusions: 
This study provides baseline assessment for the Satisfaction with life of general 
population of Pakistan and the results could be applied in clinical practice. The 
study revealed the impact of the following conditions on the various satisfac-
tion with life domains measured: Education, work, personal income & Locality. 
Overall the percentage of Pakistani people who are satisfied with their life (67.6%) 
is more as compared to the percentage of dissatisfied people. Satisfaction with 
life of general populationof pakistan could be further improved if better job and 
education opportunitiesare provided.
PIH65
dIFFeRentIals In contRacePtIve use among cuRRently maRRIed 
Women by socIo-demogRaPHIc cHaRacteRIstIcs In WesteRn kenya
Mogere DM
Great Lakes University of Kisumu, Kisumu, Kenya
outside the abdomen, or nothing at all. Participants most commonly circled at least 
one portion of the middle (89.8%) and/or lower (92.2%) abdomen. 205 participants 
(49.9%) circled the median and lower abdomen only. 73 participants (17.8%) circled 
an area inclusive of at least a portion of all nine regions of the abdomen; of these 
participants, 28 (38.4%) had a self-reported history of disease(s) with abdominal symp-
toms (e.g., irritable bowel syndrome, GERD). ConClusions: Despite relatively low 
education levels and low prevalence of diseases with abdominal symptoms, nearly 
all participants demonstrated knowledge of the general location of the abdomen. 
However, the data suggest that nearly half of participants were considering the middle 
and lower regions of the abdomen exclusively. Therefore, to obtain accurate reports of 
symptoms pertaining to a specific abdominal location, it would behoove instrument 
developers to define and identify (e.g., through an illustration), the precise anatomical 
area of interest, which should improve the reliability and validity of the PRO measure.
PIH60
usabIlIty testIng oF an IntegRated glucometeR and HandHeld 
electRonIc PatIent-RePoRted outcome system
Khurana L1, Durand E1, Gary S1, Otero T1, Hall C1, Dallabrida S2
1ERT, Boston, MA, USA, 2PHT Corporation, Boston, MA, USA
objeCtives: Clinical trials for diabetes treatment are increasingly collecting elec-
tronic patient-reported outcomes (ePRO) and physiological measurements outside 
of the clinical setting. This study examined the usability of a handheld ePRO device 
and glucometer as an integrated system for collecting, transmitting, and character-
izing blood glucose readings. Methods: Twelve subjects with type 2 diabetes were 
interviewed in the U.S. Subjects were given a handheld ePRO device (LogPad LW), 
synthetic glucose solution, and a Bluetooth-enabled MyGlucoHealth meter with 
test strips. Subjects were asked to take a glucose reading, transmit the reading to 
the handheld device, and characterize the glucose value in a diary. Interviewers 
observed subjects and conducted semi-structured interviews to determine usability 
of the devices and integration step. Results: Subjects were 47 to 67 years old and 
55% female. No major difficulties were observed by the interviewers. 100% of sub-
jects found the exercise to be easy, and easily understood how to take a glucose read-
ing, transmit it to a handheld device and to characterize the glucose reading. 75% 
of subjects reported that they would not be bothered by the size of the devices. All 
subjects (100%) reported they were willing and able to carry both devices with them 
and complete a diary outside of the home, and 88% of subjects would be willing to 
use both devices in public. When asked about additional features on the integrated 
system, 57% stated it would be helpful to review their most recent blood glucose 
readings on the handheld device, and 71% would like the ability to turn a reminder 
alarm on or off. ConClusions: An integrated handheld ePRO/glucometer system 
was found to be easy to use and acceptable to subjects with type 2 diabetes, and 
is a feasible solution for collecting, transmitting and characterizing blood glucose 
readings outside of the clinical setting.
PIH61
comPaRIson oF PatIent-RePoRted outcomes ReQuIRements In medIcal 
guIdelInes FoR PaIn, mIgRaIne, RHeumatoId aRtHRItIs, and systemIc 
luPus eRytHematosus: euRoPe vs. unIted states
Burgess SM1, Gauthier M2, Cala ML2
1Strategic Outcomes Services, Mission Viejo, CA, USA, 2Endpoint Outcomes, Boston, MA, USA
objeCtives: To enable researchers to better understand the regulatory require-
ments for inclusion of patient-reported outcome (PRO) measures as efficacy end-
points for the development and approval of drugs for generic pain and analgesic 
indications, plus three pain-related diseases (i.e., migraines, rheumatoid arthritis 
[RA], and systemic lupus erythematosus [SLE]). This research reviews, contrasts, 
and compares the European Medicines Agency (EMA) and US Food and Drug 
Administration (FDA) medical guidelines in these conditions. Methods: A targeted 
search was conducted for recent (2010-2015) European and US medical guidelines in 
the conditions mentioned. Information pertaining to PROs within these guidelines 
was extracted and compared. Attention was paid to similarities, differences, and 
gaps across these guidelines. Results: Both EMA and FDA consistently recom-
mend the use or development of reliable and valid measures across all disease 
areas and emphasized the importance of measuring symptoms from the patient 
perspective. For example, both authorities recommend the assessment of intensity 
for pain and analgesic indications; assessment of migraine-associated symptoms 
(nausea, vomiting, photophobia, phonophobia) for migraine treatment efficacy; 
and measurement of fatigue and other relevant symptoms for patients with SLE. 
For RA, the EMA recommends assessment of pain intensity through the use of a 
PRO measure. More often, EMA guidelines emphasize the requirement of assessing 
health-related quality of life (HRQoL) or functioning through PRO measures. This 
is not to say that HRQoL is not addressed by FDA guidelines (e.g., measurement of 
physical and emotional function and HRQoL in pain, assessment of physical func-
tion in RA); however, examples of specific assessments are more prominent within 
EMA guidelines. In contrast, FDA guidelines are more specific regarding how best to 
evaluate disease symptoms. ConClusions: While similarities between EMA and 
FDA medical guidelines exist, variations between guidelines highlight the need for 
sponsors to become familiar with and incorporate these guidelines early on in the 
drug development process.
PIH62
caPtuRIng emotIonal concePts duRIng concePt elIcItatIon
Forbes D1, Saunders D1, Cole JC2
1The Forbes Consulting Group, Lexington, MA, USA, 2PPD, San Diego, CA, USA
objeCtives: FDA guidance for PROs has led to an increased reliance on qualita-
tive methodologies to identify relevant domains for instrument development. 
Concept elicitation (CE), which underpins the development of PRO instruments, 
often relies on exploring patient experience through the lens of the patient as it 
relates to disease burden and the impact on activities of daily living. Yet the deeper 
emotional experience of patients is missed. We address this gap in methodology by 
